Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Briley

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Pharmacopsychiatria|January 1, 1982
High-affinity 3H-imipramine binding: a new biological marker in depressionS Z Langer, E Zarifian, M Briley, et al.
Psychopharmacology|January 1, 1993
Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effectsM B Assié, P Chopin, A Stenger, et al.
Life Sciences|July 20, 1981
High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disordersS Z Langer, E Zarifian, M Briley, et al.
Life Sciences|November 30, 1981
Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patientsL Ahtee, M Briley, R Raisman, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Muscarinic acetylcholine receptor subtypes associated with release of Alzheimer amyloid precursor derivatives activate multiple signal transduction pathwaysC C Felder, A L Ma, E M Briley, et al.
Neuropeptides|July 1, 1994
The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channelsE M Briley, S J Lolait, J Axelrod, et al.
Neuropharmacology|December 1, 1985
Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drugC Moret, M Charveron, J P Finberg, et al.
International Clinical Psychopharmacology|March 1, 1997
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerabilityA Puech, S A Montgomery, J F Prost, et al.
Science (New York, N.Y.)|December 5, 1980
High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrineS Z Langer, C Moret, R Raisman, et al.
Journal of Neurochemistry|August 1, 1981
Distribution of specific high-affinity binding sites for [3H]imipramine in human brainS Z Langer, F Javoy-Agid, R Raisman, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Pharmacopsychiatria|January 1, 1982
High-affinity 3H-imipramine binding: a new biological marker in depressionS Z Langer, E Zarifian, M Briley, et al.
Psychopharmacology|January 1, 1993
Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effectsM B Assié, P Chopin, A Stenger, et al.
Life Sciences|July 20, 1981
High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disordersS Z Langer, E Zarifian, M Briley, et al.
Life Sciences|November 30, 1981
Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patientsL Ahtee, M Briley, R Raisman, et al.
Annals of the New York Academy of Sciences|September 24, 1993
Muscarinic acetylcholine receptor subtypes associated with release of Alzheimer amyloid precursor derivatives activate multiple signal transduction pathwaysC C Felder, A L Ma, E M Briley, et al.
Neuropeptides|July 1, 1994
The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channelsE M Briley, S J Lolait, J Axelrod, et al.
Neuropharmacology|December 1, 1985
Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drugC Moret, M Charveron, J P Finberg, et al.
International Clinical Psychopharmacology|March 1, 1997
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerabilityA Puech, S A Montgomery, J F Prost, et al.
Science (New York, N.Y.)|December 5, 1980
High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrineS Z Langer, C Moret, R Raisman, et al.
Journal of Neurochemistry|August 1, 1981
Distribution of specific high-affinity binding sites for [3H]imipramine in human brainS Z Langer, F Javoy-Agid, R Raisman, et al.
Pageof 17